Breast Cancer And Pregnancy: Disease Bioinformatics
Pregnancy-associated breast cancer is defined when diagnosis of breast cancer occurs during or within a year of pregnancy. Research demonstrates that women younger than 35 with pregnancy-associated breast cancer had the same long-term outcomes as women who were not pregnant when diagnosed. However, women who were diagnosed during pregnancy typically had later-stage cancer, which may be due to the fact that pregnancy makes detection of cancerous symptoms more difficult. Women who wait to have children increase their risk for pregnancy-associated breast cancer because the hormones associated with fetal development can also help breast cancers grow. Women who began treatments while pregnant have a better 10-year survival rate than those who wait until after the child is born.
Breast Cancer And Pregnancy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Breast Cancer And Pregnancy below!
For more information on how to use Laverne, please read the How to Guide.
We have 2186 products for the study of Breast Cancer And Pregnancy that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.